Navigation Links
Harwood Feffer LLP Announces Securities Class Action Lawsuit Against Puma Biotechnology, Inc. And Advises Shareholders To Contact Harwood Feffer LLP Prior To The Lead Plaintiff Deadline
Date:6/22/2015

NEW YORK, June 22, 2015 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) announces a class action lawsuit has been filed in the United States District court for the Central District of California against Puma Biotechnology, Inc. ("Puma" or the "Company") (NYSE: PBYI), for alleged violations of the federal securities laws. Investors who purchased or otherwise acquired Puma shares between July 23, 2014 and May 13, 2015, inclusive (the "Class Period"), have until August 3, 2015 to serve as lead plaintiff in the class action. The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

Puma is a biopharmaceutical company that focuses on in-licensing cancer drug candidates that have already undergone or completed clinical testing. The complaint alleges that Puma made false and/or misleading statements and/or failed to disclose in violation of the securities laws that: (1) the Company's New Drug Application ("NDA") filing would be for a positive early stage breast cancer indication, instead of the previously announced metastatic breast cancer; (2) Puma would need to submit additional safety data from preclinical carcinogenicity studies with its NDA filing, which Puma did not have; (3) the additional studies required would push the timeline for filing the NDA into the first quarter of 2016; (4) the Company overstated results from its Phase III ExteNET trial; and (5) as a result of the foregoing, Puma lacked a reasonable basis for their positive statements concerning the Company's outlook, as well as the ongoing ExteNET trial. When the truth was revealed, the stock dropped causing damage to investors.

If you are a shareholder who suffered a loss during the Class Period and wish to discuss this matter with us, or have any questions concerning your rights and interests with regard to this matter, please contact:

Benjamin Sachs-Michaels, Esq.
Robert I. Harwood, Esq.
Harwood Feffer LLP
488 Madison Avenue
New York, New York 10022
Phone Numbers: (877) 935-7400
(212)935-7400
Email: bsachsmichaels@hfesq.com
Website: http://www.hfesq.com
Follow us on Twitter: @HarwoodFeffer

Harwood Feffer has been representing individual and institutional investors for many years, serving as lead counsel in numerous cases in federal and state courts. Please visit the Harwood Feffer LLP website (http://www.hfesq.com) for more information about the firm.

Attorney Advertising. The law firm responsible for this advertisement is Harwood Feffer LLP (www.hfesq.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Logo - http://photos.prnewswire.com/prnh/20120215/MM54604LOGO

 


'/>"/>
SOURCE Harwood Feffer LLP
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Harwood Feffer LLP Announces Investigation of Kythera Biopharmaceuticals, Inc.
2. Harwood Feffer LLP Announces Investigation of Geron Corporation
3. Harwood Feffer LLP Announces Investigation of Aerie Pharmaceuticals, Inc.
4. Harwood Feffer LLP Announces Investigation of Dietary Supplements Containing BMPEA
5. Harwood Feffer LLP Announces Investigation of Acadia Pharmaceuticals Inc.
6. Harwood Feffer LLP Announces Investigation of Advaxis, Inc.
7. Harwood Feffer LLP Announces Investigation of Avanir Pharmaceuticals, Inc.
8. Harwood Feffer LLP Announces Investigation of PDL BioPharma, Inc.
9. Harwood Feffer LLP Announces Investigation of Santarus, Inc.
10. Harwood Feffer LLP Announces Investigation of Transcept Pharmaceuticals, Inc.
11. Updated: Harwood Feffer LLP Announces Investigation of Edwards Lifesciences Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/17/2019)... ... July 17, 2019 , ... Gwinnett Family Dental ... and trusted provider of complete dental care, including general and preventative care as well ... with a large team of extensively trained dentists, Dr. Kell Gallaher, Dr. Jon Klevansky, ...
(Date:7/17/2019)... CHICAGO (PRWEB) , ... July 17, 2019 , ... ... Meeting, September 11-13, in Phoenix, will provide strategies to keep pathologists, laboratory professionals ... stewardship techniques to improve outcomes and enhance patient care. , Renowned Speakers ...
(Date:7/17/2019)... ... July 16, 2019 , ... ... announced the Best Assisted Living Communities in New York City. The research ... and more.     , AssistedLiving.org used a unique selection process which involved 39 ...
Breaking Medicine Technology:
(Date:7/17/2019)... ... July 17, 2019 , ... ... first that is capable of treating up to eight body areas simultaneously. Dr. ... body muscle toning much faster and easier than previous muscle toning devices or conventional exercise. ...
(Date:7/17/2019)... ... July 17, 2019 , ... Becker's Healthcare is pleased ... , The men and women included on this list lead organizations regularly recognized ... implementations as well as the construction of satellite clinics and strategic partnerships with ...
(Date:7/17/2019)... ... ... People considering surrogacy usually have an altruistic desire to help others who ... addition to creating a family, they have the opportunity to develop a very deep ... electing to have a child through the surrogacy process. An interview with an Intended ...
(Date:7/17/2019)... ... July 17, 2019 , ... Dr. Jonathan Zaidan, MD, FACOG, President ... WJR’s Health Woman Show. The show airs on Wednesday, July 17ths at 7pm. ... , Dr. Zaidan and co-host Ann Thomas discuss the challenges that women face when ...
(Date:7/13/2019)... ... July 12, 2019 , ... cbdMD, Inc., a ... “Brand to Watch” by Brightfield Group, a leading cannabis research firm. In their ... of domestic CBD companies in two categories, Topicals and Skincare/Beauty. , "There is ...
Breaking Medicine News(10 mins):